{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:51:08Z","timestamp":1790398268027,"version":"4.1.0"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The incidence of cytomegalovirus retinitis (CMVR) in solid organ transplant (SOT) recipients may be increasing due to improved long-term survival post-transplant. However, the epidemiology of CMVR after SOT is not well described. We therefore aimed to determine the incidence of CMVR and identify risk factors for its development post-SOT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>Case-control study at a 1:4 ratio between January 1, 2012 and March 31, 2024. Cases were SOT recipients at 1 of 2 British Columbia transplant centres diagnosed with CMVR clinically or through ocular fluid viral PCR. Controls were matched on transplant organ, year, and center. Univariable and multivariable analyses were performed using conditional logistic regression models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Out of 5877 SOT recipients followed during the study period, there were 16 CMVR cases with an incidence rate of 5.3 per 10 000 person-years. Fourteen eligible cases of CMVR were matched to 56 controls. Cases were older than controls (median age 60.9 vs 42.6 years) and more likely to have diabetes mellitus (DM) (9 [64.3%] vs 9 [16.4%]), chronic heart disease (4 [28.6%] vs 4 [7.3%]), and CMV DNAemia any time post-SOT (12 [85.7%] vs 19 [35.2%]). Most received kidney transplants (50.0%), and the median time to CMVR was 3.4 years. After adjusting for age at transplant, DM, chronic heart disease, CMV DNAemia, and significant lymphopenia, only DM was associated with an increased odds of CMVR (odds ratio 16.5 [95% confidence interval, 1.12\u2013243.8]).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>CMVR is a rare and late complication post-SOT. DM was independently associated with increased odds of CMVR post-SOT.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ofid\/ofag056","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T12:49:20Z","timestamp":1770295760000},"source":"Crossref","is-referenced-by-count":1,"title":["Diabetes Mellitus is a Risk Factor for Developing CMV Retinitis in Solid Organ Transplant Recipients: A Case-control Study"],"prefix":"10.1093","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1308-2234","authenticated-orcid":false,"given":"Dilpreet K","family":"Bharaj","sequence":"first","affiliation":[{"name":"Faculty of Medicine, University of British Columbia , Vancouver, British Columbia ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanil","family":"Dhanji","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of British Columbia , Vancouver, British Columbia ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9449-3835","authenticated-orcid":false,"given":"Elena","family":"Gurung","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of British Columbia , Vancouver, British Columbia ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4778-3702","authenticated-orcid":false,"given":"Gale","family":"Ladua","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, University of British Columbia , Vancouver, British Columbia ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9320-4499","authenticated-orcid":false,"given":"Christopher F","family":"Lowe","sequence":"additional","affiliation":[{"name":"Division of Medical Microbiology and Virology, St.Paul's Hospital , Vancouver, British Columbia ,","place":["Canada"]},{"name":"Department of Pathology and Laboratory Medicine, University of British Columbia , Vancouver, British Columbia ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4158-6955","authenticated-orcid":false,"given":"Nancy","family":"Matic","sequence":"additional","affiliation":[{"name":"Division of Medical Microbiology and Virology, St.Paul's Hospital , Vancouver, British Columbia ,","place":["Canada"]},{"name":"Department of Pathology and Laboratory Medicine, University of British Columbia , Vancouver, British Columbia ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Gill","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Nephrology, University of British Columbia , Vancouver, British Columbia ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Mah","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, University of British Columbia , Vancouver, British Columbia ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alissa J","family":"Wright","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, University of British Columbia , Vancouver, British Columbia ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2604-6205","authenticated-orcid":false,"given":"David","family":"Ta Kim","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of British Columbia , Vancouver, British Columbia ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaivon","family":"Pakzad-Vaezi","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, University of British Columbia , Vancouver, British Columbia ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1725-1407","authenticated-orcid":false,"given":"Sara","family":"Belga","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, University of British Columbia , Vancouver, British Columbia ,","place":["Canada"]},{"name":"Immunity and Infection Research Centre, Vancouver Coastal Health Research Institute , Vancouver, British Columbia ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"key":"2026022510413138300_ofag056-B1","doi-asserted-by":"crossref","first-page":"515","DOI":"10.6061\/clinics\/2015(07)09","article-title":"Cytomegalovirus infection in transplant recipients","volume":"70","author":"Azevedo","year":"2015","journal-title":"Clinics (Sao Paulo)"},{"key":"2026022510413138300_ofag056-B2","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0891-5520(05)70158-6","article-title":"Infectious complications of solid organ transplantations","volume":"15","author":"Simon","year":"2001","journal-title":"Infect Dis Clin North Am"},{"key":"2026022510413138300_ofag056-B3","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1097\/TP.0000000000004352","article-title":"Increasing proportion of high-risk cytomegalovirus donor-positive\/recipient-negative serostatus in solid organ transplant recipients","volume":"107","author":"Imlay","year":"2023","journal-title":"Transplantation"},{"key":"2026022510413138300_ofag056-B4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3390\/microorganisms8010055","article-title":"Cytomegalovirus retinitis in HIV and non-HIV individuals","volume":"8","author":"Munro","year":"2019","journal-title":"Microorganisms"},{"key":"2026022510413138300_ofag056-B5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1399-3062.2007.00241.x","article-title":"Clinical features and outcomes of cytomegalovirus retinitis after transplantation","volume":"10","author":"Eid","year":"2008","journal-title":"Transpl Infect Dis"},{"key":"2026022510413138300_ofag056-B6","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s00417-020-04871-w","article-title":"Clinical features of cytomegalovirus retinitis after solid organ transplantation versus hematopoietic stem cell transplantation","volume":"259","author":"Son","year":"2021","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2026022510413138300_ofag056-B7","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/j.transproceed.2024.08.007","article-title":"Cytomegalovirus retinitis in the modern era of solid organ transplantation","volume":"56","author":"Scherger","year":"2024","journal-title":"Transplant Proc"},{"key":"2026022510413138300_ofag056-B8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/cid\/ciw668","article-title":"Disease definitions working group of the cytomegalovirus drug development forum. Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials","volume":"64","author":"Ljungman","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2026022510413138300_ofag056-B9","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1097\/TP.0000000000005374","article-title":"The fourth international consensus guidelines on the management of cytomegalovirus in solid organ transplantation","volume":"109","author":"Kotton","year":"2025","journal-title":"Transplantation"},{"key":"2026022510413138300_ofag056-B10","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ajo.2021.03.051","article-title":"Classification criteria for cytomegalovirus retinitis","volume":"228","author":"Standardization of Uveitis Nomenclature (SUN) Working Group","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"2026022510413138300_ofag056-B11","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1007\/s00417-018-4111-9","article-title":"Diagnostic efficacy of real-time PCR for ocular cytomegalovirus infections","volume":"256","author":"Miyazaki","year":"2018","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2026022510413138300_ofag056-B12","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1002\/jmv.25189","article-title":"Transitioning cytomegalovirus viral load testing from a laboratory developed test to the cobas\u00ae CMV quantitative nucleic acid assay","volume":"90","author":"Payne","year":"2018","journal-title":"J Med Virol"},{"key":"2026022510413138300_ofag056-B13","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/TP.0000000000004360","article-title":"Absolute lymphocyte count as a marker for cytomegalovirus infection after heart transplantation","volume":"107","author":"Schoeberl","year":"2023","journal-title":"Transplantation"},{"key":"2026022510413138300_ofag056-B14","doi-asserted-by":"crossref","first-page":"ofy230","DOI":"10.1093\/ofid\/ofy230","article-title":"Absolute lymphocyte count thresholds: a simple, readily available tool to predict the risk of cytomegalovirus infection after transplantation","volume":"5","author":"Meesing","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"2026022510413138300_ofag056-B15","doi-asserted-by":"crossref","first-page":"S210","DOI":"10.1016\/j.jcjd.2017.10.027","article-title":"Retinopathy","volume":"42","author":"Diabetes Canada Clinical Practice Guidelines Expert Committee","year":"2018","journal-title":"Can J Diabetes"},{"key":"2026022510413138300_ofag056-B16","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.3390\/v16091427","article-title":"Cytomegalovirus retinitis: clinical manifestations, diagnosis and treatment","volume":"16","author":"Zhang","year":"2024","journal-title":"Viruses"},{"key":"2026022510413138300_ofag056-B17","first-page":"279","article-title":"Human cytomegalovirus end-organ disease is associated with high or low systemic viral load in preemptively treated solid-organ transplant recipients","volume":"35","author":"Gerna","year":"2012","journal-title":"New Microbiol"},{"key":"2026022510413138300_ofag056-B18","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1007\/s00417-024-06415-y","article-title":"Immune recovery uveitis: a focus review","volume":"262","author":"Rodrigues Alves","year":"2024","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2026022510413138300_ofag056-B19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/IAE.0000000000003631","article-title":"Clinical characteristics and prognostic factors affecting clinical outcomes in cytomegalovirus retinitis with or without HIV infection","volume":"43","author":"Su","year":"2023","journal-title":"Retina"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofag056\/66799473\/ofag056.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/2\/ofag056\/66799473\/ofag056.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/13\/2\/ofag056\/66799473\/ofag056.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T15:41:40Z","timestamp":1772034100000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofag056\/8466404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2,2]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofag056","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2026,2]]},"article-number":"ofag056"}}